When was Pramana founded?

Pramana was founded in 2021 and raised its 1st funding round 1 year after it was founded.

Where is Pramana located?

Pramana is headquartered in Cambridge, United States.

How many employees does Pramana have?

As of May 31, 2026, the latest employee count at Pramana is 97.

Is Pramana a funded company?

Pramana is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Mar 16, 2022.

When was the latest funding round of Pramana?

Pramana's latest funding was a $***** Seed round on Mar 16, 2022, with participation from 1 investor. Its primary sector is Healthcare IT. In United States, the Healthcare IT sector has seen $3.48B in funding in 2026 to date.

Where does Pramana rank among its competitors?

Pramana ranks 33rd amongst 276 active competitors, of which 72 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Techcyte, which secured $15M in Apr, 2026.

Who are the top competitors of Pramana?

Pramana's top competitors include PathAI, Deciphex and Aignostics. Among them, Techcyte secured the most recent funding round in April, 2026.

Pramana - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of autonomous whole slide imaging systems for digital pathology. It offers modular scanner systems featuring identical optical paths, uniform software, and a seamless user experience. The scanners handle most slide types without user intervention, and provide inline quality assurance with autonomous rescanning. It also provides edge AI capability to execute feature description algorithms in real time during the scanning process. The company offers solutions for anatomic pathology, cytopathology, hematopathology, clinical pathology, and microbiology.

Website: www.pramana.ai/
Social

Key Metrics

Founded Year

2021

Location

Cambridge, United States

Stage

Acquired

Latest Funding Round

Seed, Mar 16, 2022, $*****

Investors

NTTVC & 1 more

Ranked

33^rd among 276 active competitors

Employee Count

97 as on May 31, 2026

Similar Companies

Scopio Labs & 181 more

Exit Details

Acquired by Evident (Aug 04, 2025)

View Pramana's full profile

Pramana got acquired by Evident on Aug 04, 2025.

Click here to take a look at Pramana's acquisition in detail

Pramana has raised funding over 1 round. Its latest funding round was a Seed round on Mar 16, 2022 for $*****. 1 investor participated in its latest round. Pramana has 2 institutional investors.

Here is the list of recent funding rounds of Pramana:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 16, 2022	8252676	Seed	8134556	8093952	3971405	3113182

Access funding benchmarks and valuations. Sign up today!

View details of Pramana's funding rounds and investors

Pramana's employee count trend

Pramana has 97 employees as of May 26. Here is Pramana's employee count trend over the years:

Uncover Pramana's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Pramana include PathAI, Deciphex and Aignostics. Here is the list of Top 10 competitors of Pramana, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PathAI 2016, Boston (United States), Series C	Provider of digital pathology image management system for clinical labs	$255M	General Catalyst, Merck Global Health Innovation Fund ... & 22 others	71/100
2nd	Deciphex 2017, Dublin (Ireland), Series C	Network of pathologists providing digital diagnostic services for medical testing	$56.6M	Seroba Life Sciences, Molten Ventures & 13 others	65/100
3rd	Aignostics 2018, Berlin (Germany), Series B	Developer of artificial intelligence software for biomedical image analysis applications	$53.9M	Wellington Partners Venture Capital, Boehringer Ingelheim Venture Fund ... & 9 others	63/100
4th	Aiforia 2014, Helsinki (Finland), Public	Provider of an AI and cloud-based, deep learning image analysis platform in all therapy areas	$23M	Businessfinland, Ascend Capital Partners & 8 others	63/100
5th	Techcyte 2014, Orem (United States), Series B	Artificial intelligence (AI) based image analysis platform for pathologists	$50.4M	ARUP Laboratories, Zoetis & 2 others	61/100
6th	Nucle AI 2017, Chicago (United States), Series B	AI-assisted platform for image analysis	$60M	Vertex Ventures Israel, Sanofi Ventures & 9 others	61/100
7th	Visiopharm 2001, Horsholm (Denmark), Acquired	Developer of a SaaS and AI-based digital pathology solutions for image analysis and workflow standardization	$26.3M	BankInvest, Vaekstfonden & 4 others	60/100
8th	Scopio Labs 2014, Tel Aviv (Israel), Series D	Developer of digital imaging platforms for hematology	$125M	OTV, OurCrowd & 15 others	58/100
9th	Fibronostics 2015, Orlando (United States), Series A	Non-invasive algorithm-based diagnostics	$14.5M	AT Capital, Elev8 & 1 others	57/100
10th	LPixel 2014, Tokyo (Japan), Series A	Image analysis tools using artificial intelligence	$7M	JAFCO Group, Mistletoe & 6 others	57/100
33rd	Pramana 2021, Cambridge (United States), Acquired	Provider of autonomous whole slide imaging systems for digital pathology	-	NTTVC, Matrix Capital Markets Group	44/100